111 related articles for article (PubMed ID: 20955378)
21. p16(INK4a) promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients.
Ruesga MT; Acha-Sagredo A; Rodríguez MJ; Aguirregaviria JI; Videgain J; Rodríguez C; de Pancorbo Mde L; Aguirre JM
Cancer Lett; 2007 May; 250(1):140-5. PubMed ID: 17113222
[TBL] [Abstract][Full Text] [Related]
22. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
23. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
[TBL] [Abstract][Full Text] [Related]
24. Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions.
Lin CY; Chen WH; Liao CT; Chen IH; Chiu CC; Wang HM; Yen TC; Lee LY; Chang JT; Cheng AJ
Head Neck; 2010 Aug; 32(8):1028-39. PubMed ID: 19953611
[TBL] [Abstract][Full Text] [Related]
25. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of p16(INK4A) protein in oral lichen planus.
Montebugnoli L; Venturi M; Gissi DB; Leonardi E; Farnedi A; Foschini MP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):222-7. PubMed ID: 21612953
[TBL] [Abstract][Full Text] [Related]
28. [Expression of CDK4 protein in oral carcinogenesis].
Chen Q; Luo G; Li B; He Z; Chen L; Cao X; Nie M
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):8-10. PubMed ID: 12539309
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
30. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
31. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
[TBL] [Abstract][Full Text] [Related]
32. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
33. Nucleolar protein p120 expression in oral carcinoma.
Ventura L; Migaldi M; Criscuolo M; Castelli M; Barbolini G; Ranieri A; Bifaretti G; Uboldi P; Leocata P
Anticancer Res; 1999; 19(2B):1423-6. PubMed ID: 10365117
[TBL] [Abstract][Full Text] [Related]
34. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
35. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
[TBL] [Abstract][Full Text] [Related]
36. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
37. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
38. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
39. [Changes of simple epithelial cytokeratin during oral carcinogenesis].
Nie M; Li B; Zeng G; He Z; Chen Q; Zhou M; Luo G; Zeng X
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):208-9, 220. PubMed ID: 12539284
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions.
Ma LW; Zhou ZT; He QB; Jiang WW
J Oral Pathol Med; 2013 Jan; 42(1):47-52. PubMed ID: 22671975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]